MeSH tree: C23.550.835
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own immune arsenal to fight ...
Mar 19, 2026
0
7
Lymph nodes, considered the command centers of our immune system, often get swollen and stiff when fighting infection. Now, a UC Berkeley-led team of researchers has discovered that this mechanical change may help instruct ...
Mar 12, 2026
0
7
Sepsis moves fast. A patient can arrive at hospital with what appears to be a routine infection and, within hours, develop organ failure. Survival often depends on how quickly treatment begins. Across Europe, doctors are ...
Mar 11, 2026
0
5
A naturally occurring protein in the human body could protect people from one of the world's biggest killers—sepsis. The protein's ability to reduce inflammation in a preclinical study raises hopes that it could be the first ...
Mar 3, 2026
0
7
Traumatic injury is the third leading cause of death in the state of Texas, surpassing strokes, Alzheimer's disease and diabetes, according to the Centers for Disease Control and Prevention. A massive number of these deaths ...
Feb 18, 2026
1
46
Severe bleeding is one of the most common and preventable causes of death after traumatic injury, yet currently available tools have poor ability to determine which patients urgently need blood transfusions. A new multinational ...
Feb 5, 2026
0
55
Strapped to a stretcher in the back of an ambulance, the shooting victim moaned, then screamed. Blood splattered across the person's cheeks and neck, seeped through the gauze looped around a leg and dripped onto the floor.
Jan 5, 2026
0
7
The U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatment or relapsed after two or more prior ...
Dec 15, 2025
0
8
The chimeric antigen receptor (CAR) T cell therapy anitocabtagene autoleucel (anito-cel) continued to show strong results in treating relapsed/refractory multiple myeloma, according to new trial data from researchers at The ...
Dec 8, 2025
0
12
A systematic review and meta-analysis evaluated the association between corticosteroid therapy, mortality, and infectious complications in adults with severe non-COVID-19 pneumonia or acute respiratory distress syndrome (ARDS). ...
Dec 1, 2025
0
17
